Immunotherapy-based combinations for advanced/metastatic renal cell carcinoma: ASCO GU 2023

Explore advances in immunotherapy-based combination treatments for patients with renal cell carcinoma.
With Prof. Brian Rini, Prof. Elizabeth Plimack and Prof. Thomas Powles.
Watch now: touchoncologyime.org/congress...
--------
This activity is funded by an independent medical education grant from Merck & Co. Inc. and Exelixis Inc. and is jointly provided by USF Health and touchIME.

[@egg399.]

Is anyone working on Metabolic therapy for renal cancer?
If not, why not?